HPV VACCINE

The HPV vaccine, Cervavac is a vaccine that can prevent cervical cancer, one of the leading of female cancer mortality worldwide. It is indigenously developed by the Serum Institute of India. The vaccine has acquired market authorization from the Drugs Controller General of India.

It is India's first Quadrivalent Human Papillomavirus Vaccination (qHPV) designed to protect women from cervical cancer.

Cervical Cancer

Cervical cancer is a prevalent sexually transmitted infection.?
It’s a type of cancer that occurs in the cells of the cervix, which is the lower part of the uterus that connects to the vagina.
It is mostly caused by long-term infection with particular forms of HPV.
It is the second most prevalent cancer form and it is also the second leading cause of cancer death in women of reproductive age between 15 to 44?

Indian Perspective:

According to the World Health Organization's International Agency for Research on Cancer, India accounts for roughly one-fifth of the global burden, with more than 1.23 lakh cases and around 67,000 fatalities every year.

Significance of the new Vaccine

It’s based on VLP (Virus-Like Particles), similar to the Hepatitis-B vaccination, as it gives protection by producing antibodies against the HPV virus' L1 protein.
It is said to be effective against four strains of the virus that is Type 6, Type 11, Type 16, and Type 18.
A quadrivalent vaccine is a vaccine that works by stimulating an immune response against four different antigens, such as four different viruses or other microorganisms.
It has a significant potential to eliminate cervical cancer and it would be helpful if it will be included in national HPV vaccination efforts and offered at a lower cost than the existing vaccinations.
Existing two vaccines licensed globally are available in India, they are a quadrivalent vaccine (Gardasil, from Merck) and a bivalent vaccine (Cervarix, from GlaxoSmithKline) which are costly and none of them are included in the National Immunization Program.
After the DGCI approval, this would enable the government to procure vaccines in bulk to vaccinate around 50 million girls who are aged between 9 to 14 years.
The vaccine is extremely effective only when it's given before the first sexual intercourse.

Source: The Hindu

Join Our Telegram

Voice clone-AI

Pradhan Mantri Suryodaya Yojana

06 Feb, 24
SHARE

Recently, Prime Minister announced Pradhan Mantri Suryodaya Yojana under which 1 crore households will get rooftop solar power systems. India’s Status of Current Solar Capacity India currently stands at 4th place globally in solar power capacity. As per Ministry of New an

Foreign Contribution Regulation Act (FCRA)- NGO

06 Feb, 24
SHARE

The Foreign Contribution Regulation Act, 2010 (FCRA) registration of two prominent non-governmental organisations (NGOs) — Centre for Policy Research (CPR) and World Vision India (WVI) have been cancelled this month. What is FCRA? Key provisions of FCRA, 2010 Key aspects Description

Voice clone-AI

06 Feb, 24
SHARE

Voice clone fraud has been on the rise in India. AI voice cloning – It is the process of creating a synthetic replica of a person’s voice through machine learning and speech synthesis technology.It is called as voice deepfakesor audio deepfakes. Objective – To achieve a high level of na

Science communication- how to promote

06 Feb, 24
SHARE

Steps taken by India to promote Science Communication Publications and Information Directorate (PID) - An organisation under Council of Science and Industrial Research (CSIR) established in 1951 for publishing and disseminating scientific information in India. National science magazines- The PI

Universal Basic Income (UBI)- Analysis

05 Feb, 24
SHARE

Universal Basic Income (UBI) can strengthen welfare architecture and unlock the nation’s latent demographic potential. UBI - It is an income support mechanism typically intended to reach all or a very large portion of the population regardless of their earnings or employment status. Objective- To provide enough to co